Institute for Myeloma & Bone Cancer Research

11/09/2025

🩸The LONGEST survival for myeloma patients in the world is at Berenson Cancer Center because of our research! 🔬 Support our cancer research: IMBCR.org/ Donate

Many clinical trials have reported survival outcomes for newly diagnosed multiple myeloma (NDMM) patients. Notably, these are selected patients and, thus, do not reflect a population of unselected NDMM patients. Therefore, we conducted a retrospective study for this population treated at a single cl...

11/05/2025

🎉Huge news! IMBCR's research has helped Berenson Cancer Center's Myeloma patients have the LONGEST survival rate in the world! 💪 Reported today in Haematologica https://haematologica.org/article/view/12093
Call today for your appointment: 310-623-1222 BerensonCancerCenter.com

Many clinical trials have reported survival outcomes for newly diagnosed multiple myeloma (NDMM) patients. Notably, these are selected patients and, thus, do not reflect a population of unselected NDMM patients. Therefore, we conducted a retrospective study for this population treated at a single cl...

10/28/2025

James R. Berenson, MD talks about other options for patients who failed certain therapies. https://www.dropbox.com/scl/fi/9i1v4oo9apktbltiycspa/Dr.-Berenson-10-21-25.mp4?rlkey=pelzjxalq58lm0r4kdmokax7l&st=d6ns58r0&dl=0
IMBCR.org 310-623-1210

Shared with Dropbox

10/05/2025

Watch Dr. James Berenson's interview where he talks about a new treatment for multiple myeloma.

A video from James Berenson, posted on Sep 26, 2025.

09/22/2025

Your team at IMBCR wish you and yours a Happy and Healthy New Year.

08/23/2025

💪Mark, a grateful MM patient of Dr James Berenson celebrates three years taking a hike around Lake Tahoe. 👏 "It's important to Dr. B that patients experience their best quality of life." 

08/01/2025

Let's support an important cause: CANCER RESEARCH! For Dr. James R. Berenson's birthday, we are raising support for the groundbreaking work that the Institute for Myeloma & Bone Cancer Research (IMBCR) is conducting everyday. We have recently discovered a new target, i1, and compounds that block it which is leading to a brand-new approach to treating myeloma. Any gift will make an impact and is tax-deductible. We appreciate you and thank you for your donation. IMBCR.org/Donate

07/17/2025

📣 UPDATE on the new myeloma treatment we’ve all been working on: We’ve gotten a lot of questions asking if the new treatment we’re working on with the Institute for Myeloma & Bone Cancer Research will eventually be available outside of the US. Here’s Dr. B’s answer.

06/10/2025

We started Myeloma BioBank to help accelerate the discovery of new treatments and cures for myeloma and its related diseases; this BioBank provides support for ongoing research at the Institute for Myeloma & Bone Cancer Research (IMBCR).

We are able to provide researchers with the highest quality blood and bone marrow samples from multiple myeloma and other plasma cell dyscrasias, including MGUS, amyloidosis, and Waldenstrom’s macroglobulinemia.

05/31/2025

🎉 Last Chance to Bid on Amazing Auction Items! 🎉

Don’t miss your opportunity to win big while supporting IMBCR in the fight against cancer — our silent auction closes on Monday, June 2nd! ⏰ Check out the remaining items then email info@imbcr.org with your name, item number, and bid amount to place your final bids now! 🛍️

05/27/2025

Thank you to everybody that supported IMBCR’s Benefit Honoring Beverly and Eleda Cohen. The sold out event was so much fun. 🎉 Guests enjoyed live music, unbelievable silent auction items, and a delicious dinner. To top it off, Dr James Berenson gave an inspiring lecture “Myeloma 101” explaining what IMBCR does and the exciting groundbreaking research he and the scientists are discovering. 💪

05/27/2025

Thank you to everybody who supported IMBCR's successful sold out fundraiser. What a wonderful evening--live entertainment, a delicious dinner, and incredible silent auction items. And to top it off to learn about IMBCR and the exciting breakthrough discoveries the scientists are making in "Myeloma 101"--a lecture by Dr James Berenson.